![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Krka, D.d., Novo Mesto Novo Mesto Si, based in Slovenia, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Bacitracin zinc, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2006-052 - Rev 00
This Chemical Type CEP, issued on November 07, 2008, remains in force until November 19, 2013, ensuring its reliability within the pharmaceutical industry.
Substance Number 466 associated with this CEP further emphasizes